Haemolytic uraemic syndrome associated with OKT3.
Morris-Stiff
G
G
Evans
M
M
Baboolal
K
K
Balaji
V
V
Moore
R
R
Jurewicz
A
A
Lord
R
R
D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007511:Ischemia / Q000473:pathology; D007668:Kidney / Q000098:blood supply / Q000473:pathology; D016030:Kidney Transplantation; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects*; D011183:Postoperative Complications / Q000209:etiology*; D016559:Tacrolimus / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016559:Tacrolimus